[New fixed combination in type 2 diabetes].
机构信息
.
出版信息
MMW Fortschr Med. 2016 Apr 14;158(7):74. doi: 10.1007/s15006-016-8078-3.
PMID:27071602
Abstract
摘要
相似文献
1
[New fixed combination in type 2 diabetes].[2型糖尿病的新型固定复方制剂]
MMW Fortschr Med. 2016 Apr 14;158(7):74. doi: 10.1007/s15006-016-8078-3.
2
Glyxambi--a new combination for type 2 diabetes.格列净二甲双胍片——2型糖尿病的新型复方制剂
Med Lett Drugs Ther. 2015 Apr 27;57(1467):65-6.
3
Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetes.恩格列净/二甲双胍固定剂量复方制剂：2型糖尿病患者的综述
Expert Opin Pharmacother. 2016 Dec;17(18):2471-2477. doi: 10.1080/14656566.2016.1258062. Epub 2016 Nov 22.
4
Empagliflozin/metformin (Synjardy) for type 2 diabetes.恩格列净/二甲双胍（捷诺达）用于2型糖尿病。
Med Lett Drugs Ther. 2015 Dec 21;57(1484):172-4.
5
In brief: Trijardy XR - a new 3-drug combination for Type 2 diabetes.
Med Lett Drugs Ther. 2020 Jun 1;62(1599):88.
6
The safety of empagliflozin plus metformin for the treatment of type 2 diabetes.恩格列净联合二甲双胍治疗 2 型糖尿病的安全性。
Expert Opin Drug Saf. 2018 Aug;17(8):837-848. doi: 10.1080/14740338.2018.1497159. Epub 2018 Aug 1.
7
SGLT-2 inhibitors as second-line therapy in type 2 diabetes.钠-葡萄糖协同转运蛋白2抑制剂作为2型糖尿病的二线治疗药物
Lancet Diabetes Endocrinol. 2014 Sep;2(9):678-9. doi: 10.1016/S2213-8587(14)70135-4. Epub 2014 Jun 16.
8
[XIGDUO - fixed combination of the active ingredients dapagliflozin and metformin].[XIGDUO - 达格列净与二甲双胍活性成分的固定复方制剂]
Vnitr Lek. 2016 Mar;62(3):199-201.
9
Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: Sequential or simultaneous start?胰高血糖素样肽-1受体激动剂与钠-葡萄糖协同转运蛋白2抑制剂：序贯起始还是同时起始？
Diabetes Obes Metab. 2017 Jun;19(6):909-911. doi: 10.1111/dom.12897. Epub 2017 Mar 8.
10
Author’s response.作者回复。
Expert Opin Pharmacother. 2014 Dec;15(18):2752-3.
Zotero 插件